Podcasts

Episode 41 | Decoding Perioperative Immunotherapy In NSCLC

This episode is hosted by: Dr Pei Ni Ding, Dr Samantha Bowyer, and Mr Naveed Alam.

Decoding Perioperative Immunotherapy In NSCLC

Episode Summary

In this TOGA podcast, we provide an overview of the recent neoadjuvant, adjuvant, and perioperative IO data, the options and considerations for treatment, and the current reimbursement landscape.

Show Hosts

This episode’s host are:

Dr Pei Ni Ding, Medical Oncologist from Westmead and Nepean Hospitals Sydney
Dr Samantha Bowyer, Medical Oncologist from Sir Charles Gairdner Hospital in Perth
Mr Naveed Alam, Thoracic Surgeon from St Vincents, Epworth and Monash in Melbourne

Show links

Many emerging treatments are discussed in this podcast, and clinicians are reminded that oncology access programs are listed in the medicines access portal.

Sponsor

This episode is proudly sponsored by MSD.

Play Episode 41 | Decoding Perioperative Immunotherapy In NSCLC

More Podcasts

46 – Navigating Resistance in ALK-Positive NSCLC Patients on TKI Therapy

Podcasts
December 13, 2024

Dr Rebecca Tay is joined by Professor Ben Solomon and A/Prof Michael Ng to discuss clinical and genetic factors affecting treatment choice for ALK-Positive NSCLC

45 – The Case For IO in Early-Stage NSCLC in a Once in a Lifetime World

Podcasts
December 2, 2024

Dr Deme Karikios is joined by Dr Lauren Brown and Dr Stephen Barnett to discuss IO in early-stage NSCLC in the Australian context.

44 – LCNEC Challenges in Diagnosis and Treatment

Podcasts
November 15, 2024

A/Prof Rachel Wong is joined by Dr Patrick Hosking, Dr Mal Itchins, and Dr Sagun Parakh discuss the diagnostic markers when identifying LC-NEC.

43 – Management of Limited-Stage Small Cell Lung Cancer

Podcasts
October 1, 2024

We dive into the latest survival data from the ADRIATIC trial, as presented at ASCO 2024, which could change the treatment landscape for LS-SCLC. Joining

42 – NTRK 1, 2, 3 and Other Rare Mutations in NSCLC

Podcasts
August 30, 2024

This episode is hosted by: A/Prof Steven Kao, Prof Wendy Cooper, and Prof Ben Solomon

40 – Access to New Medicines: Which Surrogate Endpoints Matter

Podcasts
July 30, 2024

This episode is hosted by: Dr Rebecca Tay, Professor Nick Pavlakis, and Dr Deme Karikios.

Join our community – stay up to date with the latest research, TOGA news and events

The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.

Contact

PO Box 1103
Thornbury VIC 3071
Ph: +61 3 9087 3550
ABN: 47 641 984 198

TOGA

Quicklinks

Thoracic Oncology Group of Australasia is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity. Donations $2 and over are tax deductible.